Skip to main content
(
Log in
)
Side panel
MENU
Dashboard
Home
About Us
About Us
FAQs
The Frank Foundation
Board Members
Publications
Quality Assurance
Guests
Learners
Mentors
Universities
Courses
All Courses
Medicine Courses
Public Health Courses
Community Health Courses
Professional Development Courses
Nursing Courses
Health Sciences
Sciences
Programs
Addiction Training for Health Professionals
Public Health U - MPH
Primary Education STEPS
Humanitarian U
Connect
Contact Us
Volunteer
Careers
Join Our Network
sign up for our newsletter
Donate
Blog
Adult Cardiovascular Disease Prevention
Polypharmacy and Comorbidity in Heart Failure
Read the entire article
. (5 minutes)
BMJ
- 2003
Click
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC192833/
link to open resource.
◄ Race and Drug Toxicity: A Study of Three Cardiovascular Drugs with Strong Pharmacogenetic Recommendations
Jump to...
Jump to...
Course Registration
Peer Corner
Pre-Test
Announcements
Improving Inclusion of Under-Served Groups in Clinical Research: Guidance from INCLUDE Project
Tools for Implementing an Evidence-Based Approach in Public Health Practice
Research Design and Methodology
Factors to Consider During Identification and Invitation of Individuals in a Multi-stakeholder Research Partnership
Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evidence
7 Data Collection Methods & Tools For Research
Biases and Confounding
Estimating Cost-Effectiveness in Public Health: A Summary of Modelling and Valuation Methods
Scenario Activity 1: Public Health Interventions (60 minutes)
The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health
Know Your Risk for Heart Disease
Screening for Cardiovascular Disease Risk and Subsequent Management in Low and Middle Income Countries: Challenges and Opportunities
Social Determinants of Cardiovascular Disease
Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health
What is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
Scenario Activity 2: Public Health Interventions in Cardiology (90 minutes)
Quiz: Module 1
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2021 ESCGuidelines on Cardiovascular Disease Prevention in Clinical Practice
Atherosclerosis
Atherosclerosis
Role of Inflammation in Atherosclerosis
Hormones of the Cardiovascular System
Environmental Determinants of Cardiovascular Disease
Impact of Therapeutic Lifestyle Changes in Resistant Hypertension
Scenario Activity 3: Cardiovascular Biology (60 minutes)
Know Your Risk for Heart Disease
Lifestyle Strategies for Risk Factor Reduction, Prevention, and Treatment of Cardiovascular Disease
Lipid-Lowering Drug Therapy
Renin Angiotensin Aldosterone Inhibition in the Treatment of Cardiovascular Disease
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
Antihypertensive Drugs and Lipids
Medication Interactions: Food, Supplements and Other Drugs
Modification of Cardiovascular Drugs in Advanced Heart Failure: A Narrative Review
Cardiovascular Pharmacotherapy in Older People: Challenges Posed by Cardiovascular Drug Prescription in the Elderly
Gender Differences and Cardiovascular Drugs | Ten Points to Remember
Race and Drug Toxicity: A Study of Three Cardiovascular Drugs with Strong Pharmacogenetic Recommendations
Anti-atherosclerotic Therapies: Milestones, Challenges, and Emerging Innovations
Why Combination Lipid-Lowering Therapy Should be Considered Early in the Treatment of Elevated LDL-C For CV Risk Reduction
Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association
Scenario Activity 4: Cardiovascular Pharmacology (60 minutes)
Quiz: Module 2
Pharmacogenomics of Adverse Drug Reactions
Cardiovascular Risk Assessment: The Foundation of Preventive Cardiology
Risk Prediction Tools in Cardiovascular Disease Prevention
Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5
Deep Phenotyping for Precision Medicine
Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5
Six Components Necessary for Effective Public Health Program Implementation
The ABCs of Primary Cardiovascular Prevention: 2019 Update
Resource Effective Strategies to Prevent and Treat Cardiovascular Disease
Prevention of Cardiovascular Disease: Recent Achievements and Remaining Challenges
Social Determinants of Cardiovascular Disease
Scenario Activity 5: Multifactorial Cardiovascular Risk Profiles (60 minutes)
Cardiovascular Disease is on the Rise, but we know how to Curb it. We’ve done it Before
Cardiovascular Disease Burden, Deaths Are Rising Around the World
Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?
Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth
Cardiovascular Disease in Chronic Kidney Disease
Cardiovascular Disease and COPD: Dangerous Liaisons?
Preeclampsia, Gestational Diabetes and Later Risk of Cardiovascular Disease: Women’s Experiences and Motivation for Lifestyle Changes Explored in Focus Group Interviews
Erectile Dysfunction: A sign of Heart Disease?
Association of Sleep Disturbance with Risk of Cardiovascular Disease and all-cause Mortality in Patients with new-onset Type 2 Diabetes: Data from the Korean NHIS-HEALS
The Risks or Lack Thereof of Migraine Treatments in Vascular Disease
Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors
Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors US Preventive Services Task Force Recommendation Statement
Challenges in the Prevention of Cardiovascular Diseases: Traditional and non-traditional Risk Factors
Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: A Systematic Evidence Report for the U.S. Preventive Services Task Force [Internet]
Risk Assessment for Cardiovascular Disease Prevention: Comparing the American and European Approaches
Cardiac Risk Assessment
Referral Outcomes of Individuals Identified at High Risk of Cardiovascular Disease by Community Health Workers in Bangladesh, Guatemala, Mexico, and South Africa
Blood Tests to Better Predict Cardiovascular Risk
Cardiac Risk Assessment
Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association
Communication Approaches to Enhance Patient Motivation and Adherence in Cardiovascular Disease Prevention
Scenario Activity 6: Managing Non-traditional Cardiovascular Risk Factors (60 minutes)
Quiz: Module 3
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: A Systematic Evidence Report for the U.S. Preventive Services Task Force
Risk Assessment for Cardiovascular Disease with Nontraditional Risk Factors: Recommendation Statement
Defining Preventive Cardiology: A Clinical Practice Statement from the American Society for Preventive Cardiology
International Charter on Cardiovascular Prevention and Rehabilitation: A Call for Action
Cardiac Rehabilitation and Its Essential Role in the Secondary Prevention of Cardiovascular Diseases
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
EXERCISE CAPACITY AND FUNCTIONAL TESTING
Clinician Guide to the ABCs of Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease
The Beneficial Effects of Cardiac Rehabilitation
Cardiac Rehabilitation
Cardiac Rehabilitation Program
What is the FITT Principle? Frequency, Intensity, Time, Type… and How they Relate to Cardio, Strength, Stretching and Injury Prevention.
Exercise Prescription Techniques in Cardiac Rehabilitation Centers in Midwest States
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
Guideline-directed Medical Therapy in Heart Failure Patients: Impact of Focused Care Provided by a Heart Failure Clinic in Comparison to General Cardiology out-patient Department
Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel
Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association
Significance of Psychosocial Factors in Cardiology: Update 2018
Scenario Activity 7: Prevention and Rehabilitation (45 minutes)
Primary, Secondary and Tertiary Prevention
FITT-CORRECT: Updated Dynamic and Evidence-based Principle of Exercise Prescription
Comorbidity in Patients with Cardiovascular Disease in Primary Care: A Cohort Study with Routine Healthcare Data
CIED Management
Guidance on the Management of Left Ventricular Assist Device (LVAD) Supported Patients for the non-LVAD Specialist Healthcare Provider: Executive Summary
Developing a Heart Transplantation Self-Management Support Mobile Health App in Taiwan: Qualitative Study
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
Referral and Participation in Cardiac Rehabilitation of Patients Following Acute Coronary Syndrome; Lessons Learned
Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease: JACC State-of-the-Art Review
Scenario Activity 8: Managing a Secondary Prevention and Rehabilitation Programme (90 minutes)
Exercise-Based Rehabilitation Delivery Models in Comorbid Chronic Pulmonary Disease and Chronic Heart Failure
Cardiovascular Disease, Cancer, and Multimorbidity Interactions: Clinical Implications
Shared Genetic Risk Factors Between Cancer and Cardiovascular Diseases
Shared Risk Factors in Cardiovascular Disease and Cancer
The cancer Patient and Cardiology
Prevalence and Prognosis Significance of Cardiovascular Disease in Cancer Patients: A Population-based Study
Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors
Cardiovascular Disease, Risk Factors, and Health Behaviors Among Cancer Survivors and Spouses: A MEPS Study
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors
The Benefits of Exercise in Cancer Patients and the Criteria for Exercise Prescription in Cardio-oncology
Exercise Capacity and Functional Testing
Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association
Scenario Activity 9: Cardiovascular Prevention and Rehabilitation Programme for an Oncology Patient (120 minutes)
Quiz: Module 4
Heart Problems: Investigating the Cardiac Side Effects of Cancer Treatments
Survival of cancer patients with pre-existing heart disease
Scenario Activities
Anti-atherosclerotic Therapies: Milestones, Challenges, and Emerging Innovations ►
ACVDP
General
How to create an account and enroll in the course?
Adult Cardiovascular Disease Prevention Homepage
Module 1: Epidemiology, Public Health and Preventive Cardiology
Module 1: Lesson 1: Public Health Interventions
Module 1: Lesson 2: Public Health Interventions in Cardiology
Module 2: Aetiology and Pathophysiology of Atherosclerosis
Module 2: Lesson 1: Cardiovascular Biology
Module 2: Lesson 2: Cardiovascular Pharmacology
Module 3: Primary Prevention and Risk Factor Management
Module 3: Lesson 1: Multifactorial Cardiovascular Risk Profiles
Module 3: Lesson 2: Managing Non-traditional Cardiovascular Risk Factors
Module 4: Secondary Prevention and Cardiovascular Rehabilitation
Module 4: Lesson 1: Prevention and Rehabilitation
Module: 4: Lesson 2: Managing a Secondary Prevention and Rehabilitation Programme
Module 4: Lesson 3: Cardiovascular Prevention and Rehabilitation Programme for an Oncology Patient
Final Exam
Course and Self Evaluation & Certificate
Course Activities
Home
